相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay-Sachs or Sandhoff variants)
Joe T. R. Clarke et al.
MOLECULAR GENETICS AND METABOLISM (2011)
The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations
Helena Poupetova et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Induced secretion of β-hexosaminidase by human brain endothelial cells: A novel approach in Sandhoff disease?
Lionel Batista et al.
NEUROBIOLOGY OF DISEASE (2010)
Lending a helping hand, screening chemical libraries for compounds that enhance β-hexosaminidase A activity in GM2 gangliosidosis cells
Michael B. Tropak et al.
FEBS JOURNAL (2007)
Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis
Gustavo H. B. Maegawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported
Gustavo H. B. Maegawa et al.
PEDIATRICS (2006)
Effective gene therapy in an authentic model of Tay-Sachs-related diseases
M. Begona Cachon-Gonzalez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease
S Martino et al.
HUMAN MOLECULAR GENETICS (2005)
Late-onset Tay-Sachs disease: Phenotypic characterization and genotypic correlations in 21 affected patients
O Neudorfer et al.
GENETICS IN MEDICINE (2005)
Surveillance for rare disorders by the BPSU
C Verity et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2002)
Tay-Sachs disease screening and counseling families at risk for metabolic disease
VR Sutton
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2002)